On BPIQ.com we report when companies have been acquired and whether company assets are still in the database (depending on the buying company). Acquired companies were briefly commented on in the IPO forum post and blog post where we presented a table of the ten smid-cap biopharma companies in our database that have been acquired by other companies within the last year. See our forum post HERE for an in depth look at these companies. Since the first “acquired smid-cap company” post in October 2021, two companies have been acquired and one removed their public trading listing. One previously announced acquisition was completed in November 2021 and an additional acquisition is expected by the end of 2021.
Want to get Catalyst Events and stocks to watch sent directly to your inbox each week? sign up for our free weekly newsletter
After an acquisition deal is announced, time passes before the deal closes, if it closes. The market share and complexity of the companies in the transaction affects how much time it takes for an announced deal to close, or break down. After they are announced, deals are subject to shareholder approval and approval of the U.S. Security and Exchange Committee (SEC) / and similar agencies in other countries. Thus, after a deal is announced the underlying stock typically is priced at some discount to the agreed upon acquisition price based on the perceived amount of risk that a deal will not be approved. Some investors invest in companies after a deal is announced to take advantage of the current price of the underlying stock versus the share price that was agreed upon if the deal gets approved by shareholders and regulators.
Companies who have been acquired are removed from the BPIQ database. Assets of acquired companies which have been acquired by large biopharma companies are typically no longer in the BPIQ.com database. However, assets of companies acquired by other smid-cap biopharma companies will continue to be in our database. They will appear on the company page for the acquiring company. See our full forum post HERE to learn more about these acquired companies.
If you are serious about investing in biotech stocks BPIQ is the research companion that will take you to the next level.
Save yourself time by accessing our database of over 550 companies, 1,800+ of their drug assets, and tools including: Catalyst Calendar, Big Movers, Company Pipelines, and more!
P.S. We are currently running a sale - lock in the price before it's gone
See what our members are saying about us:
Mike from United States
“Really loving the site over the competitor... like the layout and speed over the competition...like the individual pages for each drug/treatment”
Carl from United States
“I like your service. I haven’t seen anyone else doing something similar...nothing like this available for retail.”
Essey from Canada
“Love what you’re doing, this website is awesome.”
James from United States
Great site and I see it’s a family run business, great job.”